Sign in
4

Changes in Ownership

Aprea Therapeutics, Inc. Filed Acc 0001104659-21-117446

SVP, Chief Medical Officer sold 15,968 shares at $4.68 ($74,730)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Attar Eyal C. SVP, Chief Medical Officer 2021-09-16 Sale −15,968 $4.68 $74,730 83,000 D: show line 1 in the form
Open-market sales · 15,968 sh · avg $4.68 · $74,730
Loading xslF345X03/tm2127534-2_4seq1.xml…